Study of Cabozantinib With Lu-177 in Patients With Somatostatin Receptor 2 Positive Neuroendocrine Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Cabozantinib
Related studies linked through entity extraction aliases.
Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Autologous Dendritic Cell Vaccine in Kidney Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Survey of Cabozantinib Tablets Used To Treat People With Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Cabozantinib and Pembrolizumab in Metastatic Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
- Status
- RECRUITING
- Phase
- PHASE2
Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- N/A